Concourse Financial Group Securities’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Hold
0
11256
2022
Q2
Hold
0
11029
2022
Q1
Hold
0
10780
2021
Q4
Hold
0
10314
2021
Q3
Hold
0
9567
2021
Q2
Hold
0
9005
2021
Q1
Hold
0
8358